Takuji Kumagai

Dr. Takuji Kumagai


Research Focus & Metrics

Academic Career Length

28Years (1999-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 September 2004 in Vaccine
Verified
Journal Article
Closed access
TKTakuji Kumagai
Takuji Kumagai
KNKazushige Nagai
Kazushige Nagai
TOToyo Okui
Toyo Okui
HTHiroyuki Tsutsumi
Hiroyuki Tsutsumi
NNNobuo Nagata
Nobuo Nagata
HKHitoshi Kamiya
Hitoshi Kamiya

14 February 2000 in Vaccine
Verified
Journal Article
Closed access
TKTakuji Kumagai
Takuji Kumagai
TOTakao Ozaki
Takao Ozaki
MKMakoto Kamada
Makoto Kamada
CIChiharu Igarashi
Chiharu Igarashi
KYKenji Yuri
Kenji Yuri
SYShoki Yano
Shoki Yano

1 September 1999 in The Journal of Infectious Diseases
Verified
Journal Article
Open access
PDF file
TKTakuji Kumagai
Takuji Kumagai
MKMakoto Kamada
Makoto Kamada
CIChiharu Igarashi
Chiharu Igarashi
KYKenji Yuri
Kenji Yuri
HFHidetsugu Furukawa
Hidetsugu Furukawa
SYShoki Yano
Shoki Yano
The time course of primary cell-mediated immune responses to varicella-zoster virus (VZV) among persons receiving acyclovir prophylaxis after exposur

3 December 2013 in Human Vaccines & Immunotherapeutics
Verified
Journal Article
Open access
PDF file
YKYasuyo Kashiwagi
Yasuyo Kashiwagi
AMAkiko Miyata
Akiko Miyata
TKTakuji Kumagai
Takuji Kumagai
KMKouji Maehara
Kouji Maehara
ESEitarou Suzuki
Eitarou Suzuki
TNTetsuo Nakayama
Tetsuo Nakayama
Haemophilus influenzae type b (Hib) and 7-valent pneumococcal (PCV7) vaccines both became recommended in Japan in 2010. In this study, cytokine production was investigated in peripheral blood mononuclear cells (PBMCs) cultures stimulated with diphtheria and tetanus toxoids combined with acellular pertussis vaccine (DPT), Hib, and PCV7 separately or concurrent different combinations, all as final off-the-shelf vaccines without the individual vaccine components as controls. Higher IL-1β levels were produced when cultures were stimulated with PCV than with DPT or Hib, and the concurrent stimulation including PCV7 enhanced the production of IL-1β. Although Hib induced higher levels of IL-6, no significant difference was observed in IL-6 production with the concurrent stimulation. The concurrent stimulation with Hib/PCV7 and DPT/Hib/PCV7 produced higher levels of TNF-α and human G-CSF. Cytokine profiles were examined in serum samples obtained from 61 vaccine recipients with febrile reactions and 18 recipients without febrile illness within 24 h of vaccination. No significant difference was observed in cytokine levels of IL-1β, IL-4, IL-6, IL-10, IL-12, IFN-γ, MIP-1, TNF-α, and prostaglandin E2 (PGE2) in sera between the two groups. However, significantly higher levels of human G-CSF were observed in recipients with febrile illness than in those without febrile reactions. Further investigations of the significance of elevated serum G-CSF levels are required in vaccine recipients with febrile illness.

20 April 2006 in Journal of Medical Virology
Verified
Journal Article
Closed access
PDF file
TKTakuji Kumagai
Takuji Kumagai
TYTetsushi Yoshikawa
Tetsushi Yoshikawa
MYMariko Yoshida
Mariko Yoshida
TOToyo Okui
Toyo Okui
MIMasaru Ihira
Masaru Ihira
YAYoshizo Asano
Yoshizo Asano

27 March 2020 in Vaccines
Verified
Journal Article
Open access
PDF file
TITakashi Ito
Takashi Ito
TKTakuji Kumagai
Takuji Kumagai
YYYoshiaki Yamaji
Yoshiaki Yamaji
ASAkihito Sawada
Akihito Sawada
TNTetsuo Nakayama
Tetsuo Nakayama
Recombinant measles AIK-C vaccine expressing the hemagglutinin (HA) protein of influenza A/Sapporo/107/2013(H1N1pdm) (MVAIK/PdmHA) was constructed. Measles particle agglutination (PA) and influenza hemagglutinin inhibition (HI) antibodies were induced in cotton rats immunized with MVAIK/PdmHA. Cotton rats immunized with two doses of the HA split vaccine were used as positive controls, and higher HI antibodies were detected 3 weeks after the first dose. Following the challenge of A/California/07/2009(H1N1pdm), higher viral loads (107 TCID50/g) were detected in the lung homogenates of cotton rats immunized with the empty vector (MVAIK) or control groups than those immunized with MVAIK/Pdm HA (103 TCID50/g) or the group immunized with HA split vaccine (105 TCID50/g). Histopathologically, destruction of the alveolar structure, swelling of broncho-epithelial cells, and thickening of the alveolar wall with infiltration of inflammatory cells and HA antigens were detected in lung tissues obtained from non-immunized rats and those immunized with the empty vector after the challenge, but not in those immunized with the HA spilt or MVAIK/PdmHA vaccine. Lower levels of IFN-α, IL-1β, and TNF-α mRNA, and higher levels of IFN-γ mRNA were found in the lung homogenates of the MVAIK/PdmHA group. Higher levels of IFN-γ mRNA were detected in spleen cell culture from the MVAIK/PdmHA group stimulated with UV-inactivated A/California/07/2009(H1N1pdm). In conclusion, the recombinant MVAIK vaccine expressing influenza HA protein induced protective immune responses in cotton rats.